A human IgE bispecific antibody shows potent cytotoxic capacity mediated by monocytes
Open Access
- 16 June 2022
- journal article
- research article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 298 (8) , 102153
Abstract
No abstract availableKeywords
Funding Information
- European Commission
- Instituto de Salud Carlos III
- Horizon 2020 Framework Programme
- Horizon 2020
- European Regional Development Fund (0011-1411-2020-000075)
- H2020 Marie Skłodowska-Curie Actions (765394, PI19/01128)
This publication has 34 references indexed in Scilit:
- Crosstalk between Human IgG Isotypes and Murine Effector CellsThe Journal of Immunology, 2012
- Animal models for IgE-meditated cancer immunotherapyCancer Immunology, Immunotherapy, 2011
- Targeting HER2/neu with a fully human IgE to harness the allergic reaction against cancer cellsCancer Immunology, Immunotherapy, 2011
- New developments in FcεRI regulation, function and inhibitionNature Reviews Immunology, 2007
- Regulation of IgE homeostasis, and the identification of potential targets for therapeutic interventionBiomedicine & Pharmacotherapy, 2007
- Activity of human monocytes in IgE antibody‐dependent surveillance and killing of ovarian tumor cellsEuropean Journal of Immunology, 2003
- THE HIGH-AFFINITY IgE RECEPTOR (FcεRI): From Physiology to PathologyAnnual Review of Immunology, 1999
- An efficient route to human bispecific IgGNature Biotechnology, 1998
- Stable heterodimers from remodeling the domain interface of a homodimer using a phage display libraryJournal of Molecular Biology, 1997
- fos andjun interaction: The role of the leucine zipperInternational Journal of Cancer, 1989